NCT03812367View on ClinicalTrials.gov

Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 1, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

December 31, 2021

Conditions
Osteoporosis, Postmenopausal
Trial Locations (1)

95817

UC Davis Health, Center for Musculoskeletal Health, Sacramento

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

University of California, Davis

OTHER